ECSP982521A - CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) - Google Patents

CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I)

Info

Publication number
ECSP982521A
ECSP982521A ECSP982521A ECSP982521A EC SP982521 A ECSP982521 A EC SP982521A EC SP982521 A ECSP982521 A EC SP982521A EC SP982521 A ECSP982521 A EC SP982521A
Authority
EC
Ecuador
Prior art keywords
crystal modification
medicinal substance
active medicinal
modification
active
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Martin Szelagiewicz
Andreas Burkhard
Robert Portmann
Urs Christoph Hofmeier
Walter Scherrer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982521 priority Critical patent/ECSP982521A/en
Publication of ECSP982521A publication Critical patent/ECSP982521A/en

Links

Abstract

La invención se refiere a la nueva modificación A, o bien A¿del compuesto 1-2(2,6-difluorbencial)-1H-1,2,3, triazol-4-carboxamida de la fórmula (gráfico), su empleo, así como preparados farmacéuticos que contienen esta modificación a cristal.The invention relates to the new modification A, or A¿ of compound 1-2 (2,6-difluorobenz) -1H-1,2,3, triazol-4-carboxamide of the formula (graph), its use, as well as pharmaceutical preparations containing this crystal modification.

ECSP982521 1998-06-05 1998-06-05 CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) ECSP982521A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982521 ECSP982521A (en) 1998-06-05 1998-06-05 CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982521 ECSP982521A (en) 1998-06-05 1998-06-05 CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I)

Publications (1)

Publication Number Publication Date
ECSP982521A true ECSP982521A (en) 1999-02-11

Family

ID=42043442

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982521 ECSP982521A (en) 1998-06-05 1998-06-05 CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I)

Country Status (1)

Country Link
EC (1) ECSP982521A (en)

Similar Documents

Publication Publication Date Title
BR0207726A (en) Pharmaceutical Salts
ES2179910T3 (en) CRYSTAL MODIFICATION OF THE CDCH, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
EE03969B1 (en) (Methylsulfonyl) phenyl-2- (5H) -furanones, their Use and Pharmaceutical Compositions
ES2159591T3 (en) COMPOSITION OF CONTROLLED RELEASE.
AR003938A1 (en) TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DE60030741D1 (en) CHINAZOLINE COMPOUNDS AS A REMEDY
ES2145913T3 (en) METALOPROTEASE INHIBITORS.
BR9909565A (en) Bicyclic derivatives of hydroxamic acid
EA200000759A1 (en) DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA
BR9917007A (en) Ccr5 modulators
BR9916585A (en) Ccr5 modulators
DK0994710T4 (en) Pharmaceutical compositions for oral administration comprising a benzylhydrylpiperazine and a cyclodextrin
ES2171723T3 (en) 3,4-DIARIL-2-HYDROXI-2,5-DIHYDROFURANS AS COX-2 INHIBITORS PROPHARMS.
BR0111678A (en) Medicinal compositions containing propenone derivatives
SV1998000119A (en) DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE. REF. READ 32671-SV
CO4940452A1 (en) CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
DE60128100D1 (en) ANALGICAL DRUG
BR9913982A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
ES2140672T3 (en) REPLACED BICYCLE COMPOUNDS, MERGED AND BRIDGES USED AS THERAPEUTIC AGENTS.
ECSP982521A (en) CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I)
DK576887A (en) PHARMACEUTICAL AGENTS
ECSP982522A (en) GLASS MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (II)
UY27372A1 (en) DERIVATIVES OF BENCIMIDAZOL 1-ARIL-2-N, S OR O-SUBSTITUTES, ITS USE FOR THE OBTAINING OF PHARMACEUTICAL DRUGS AND PREPARATIONS CONTAINING THESE DERIVATIVES